|
|
||||||||
The Journal of Immunology, Vol 155, Issue 3 1489-1501, Copyright © 1995 by American Association of Immunologists
ARTICLES |
P Shrikant, E Weber, T Jilling and EN Benveniste
Department of Cell Biology, University of Alabama at Birmingham 35294, USA.
The central nervous system contains two major glial cell types, astrocytes and microglia, which function as immune effector cells within the central nervous system. We have been studying the ability of glial cells to express gene products involved in immune responsiveness, with an emphasis on expression of ICAM-1. We demonstrated previously that three proinflammatory cytokines, TNF-alpha, IL-1 beta, and IFN- gamma, as well as IFN-gamma plus LPS, can enhance ICAM-1 expression by primary rat astrocytes. In this study, we examined ICAM-1 expression by primary rat microglia and found that only IFN-gamma and IFN-gamma/LPS enhance ICAM-1 gene expression. These data indicate that ICAM-1 expression by astrocytes and microglia is enhanced differentially by various proinflammatory cytokines. We next examined the effect of two cytokines, IL-10 and IL-6, on ICAM-1 expression. IL-10 alone has no effect on ICAM-1 expression, but it inhibits the enhancement of ICAM-1 intracellular and membrane protein expression in both cell types, although it has no influence on ICAM-1 steady-state mRNA levels. These results suggest that IL-10 affects ICAM-1 expression at the translational and/or post-translational level. IL-6 alone also had no effect on ICAM-1 expression in either astrocytes or microglia, but it inhibited induction of both ICAM-1 mRNA and protein expression in these cells. Inhibition of ICAM-1 mRNA steady-state levels by IL-6 was not the result of degradation of the ICAM-1 message, suggesting an effect at the transcriptional level. Thus, both IL-10 and IL-6 can inhibit ICAM-1 expression by glial cells, although they do so by contrasting mechanisms.
This article has been cited by other articles:
![]() |
A. Lunemann, J. D. Lunemann, S. Roberts, B. Messmer, R. B. da Silva, C. S. Raine, and C. Munz Human NK Cells Kill Resting but Not Activated Microglia via NKG2D- and NKp46-Mediated Recognition J. Immunol., November 1, 2008; 181(9): 6170 - 6177. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Brantley, L. B. Nabors, G. Y. Gillespie, Y.-H. Choi, C. A. Palmer, K. Harrison, K. Roarty, and E. N. Benveniste Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression Clin. Cancer Res., August 1, 2008; 14(15): 4694 - 4704. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Shelton, T. S. Kern, and J. J. Mieyal Glutaredoxin Regulates Nuclear Factor {kappa}-B and Intercellular Adhesion Molecule in Muller Cells: MODEL OF DIABETIC RETINOPATHY J. Biol. Chem., April 27, 2007; 282(17): 12467 - 12474. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lehnardt, C. Lachance, S. Patrizi, S. Lefebvre, P. L. Follett, F. E. Jensen, P. A. Rosenberg, J. J. Volpe, and T. Vartanian The Toll-Like Receptor TLR4 Is Necessary for Lipopolysaccharide-Induced Oligodendrocyte Injury in the CNS J. Neurosci., April 1, 2002; 22(7): 2478 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Denis, K. Kwack, S. Saffaripour, S. Maganti, P. Andre, R. G. Schaub, and D. D. Wagner Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models Blood, January 15, 2001; 97(2): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lee, K. Drabik, N. J. Van Wagoner, S. Lee, C. Choi, Y. Dong, and E. N. Benveniste ICAM-1-Induced Expression of Proinflammatory Cytokines in Astrocytes: Involvement of Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Pathways J. Immunol., October 15, 2000; 165(8): 4658 - 4666. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kutsch, J.-W. Oh, A. Nath, and E. N. Benveniste Induction of the Chemokines Interleukin-8 and IP-10 by Human Immunodeficiency Virus Type 1 Tat in Astrocytes J. Virol., October 1, 2000; 74(19): 9214 - 9221. [Abstract] [Full Text] |
||||
![]() |
P. K. Henke, L. A. DeBrunye, R. M. Strieter, J. S. Bromberg, M. Prince, A. M. Kadell, M. Sarkar, F. Londy, and T. W. Wakefield Viral IL-10 Gene Transfer Decreases Inflammation and Cell Adhesion Molecule Expression in a Rat Model of Venous Thrombosis J. Immunol., February 15, 2000; 164(4): 2131 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bourrie, E. Bribes, M. Esclangon, L. Garcia, J. Marchand, C. Thomas, J.-P. Maffrand, and P. Casellas The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: Implications for multiple sclerosis treatment PNAS, October 26, 1999; 96(22): 12855 - 12859. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huaux, M. Arras, A. Vink, J.-C. Renauld, and D. Lison Soluble Tumor Necrosis Factor (TNF) Receptors p55 and p75 and Interleukin-10 Downregulate TNF-alpha Activity during the Lung Response to Silica Particles in NMRI Mice Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 137 - 145. [Abstract] [Full Text] |
||||
![]() |
N. J. Van Wagoner, J.-W. Oh, P. Repovic, and E. N. Benveniste Interleukin-6 (IL-6) Production by Astrocytes: Autocrine Regulation by IL-6 and the Soluble IL-6 Receptor J. Neurosci., July 1, 1999; 19(13): 5236 - 5244. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Palma, R. L. Yauch, S. Lang, and B. S. Kim Potential Role of CD4+ T Cell-Mediated Apoptosis of Activated Astrocytes in Theiler's Virus-Induced Demyelination J. Immunol., June 1, 1999; 162(11): 6543 - 6551. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deckert-Schluter, H. Bluethmann, N. Kaefer, A. Rang, and D. Schluter Interferon-{gamma} Receptor-Mediated but Not Tumor Necrosis Factor Receptor Type 1- or Type 2-Mediated Signaling Is Crucial for the Activation of Cerebral Blood Vessel Endothelial Cells and Microglia in Murine Toxoplasma Encephalitis Am. J. Pathol., May 1, 1999; 154(5): 1549 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Soriano, A. Coxon, Y. F. Wang, M. P. Frosch, S. A. Lipton, P. R. Hickey, T. N. Mayadas, and P. H. Chan Mice Deficient in Mac-1 (CD11b/CD18) Are Less Susceptible to Cerebral Ischemia/Reperfusion Injury • Editorial Comment Stroke, January 1, 1999; 30(1): 134 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Tebo, H. S. Kim, J. Gao, D. A. Armstrong, and T. A. Hamilton Interleukin-10 Suppresses IP-10 Gene Transcription by Inhibiting the Production of Class I Interferon Blood, December 15, 1998; 92(12): 4742 - 4749. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Oh, N. J. Van Wagoner, S. Rose-John, and E. N. Benveniste Role of IL-6 and the Soluble IL-6 Receptor in Inhibition of VCAM-1 Gene Expression J. Immunol., November 1, 1998; 161(9): 4992 - 4999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Song, H. Ling-Hu, K. A. Roebuck, M. F. Rabbi, R. P. Donnelly, and A. Finnegan Interleukin-10 Inhibits Interferon-gamma -Induced Intercellular Adhesion Molecule-1 Gene Transcription in Human Monocytes Blood, June 15, 1997; 89(12): 4461 - 4469. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |